Release
📈 Stocks
Eisai Unveils New LENVIMA Oncology Data at ESMO Congress 2026
(3 days ago)
Eisai Co. shares new Phase 3 clinical data for its LENVIMA-based oncology pipeline, focusing on advanced renal cell carcinoma treatment efficacy and…